A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD
{{output}}
Background: NS2359 is a potent reuptake blocker of noradrenalin, dopamine, and serotonin. The aim of the study was to investigate the efficacy, safety and cognitive function of NS2359 in adults with a DSM IV diagnosis of ADHD. ... ...
